Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: India
6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Ahmedabad, Allahabād, Bangalore, Bhopal, Chhatrapati Sambhajinagar, Lucknow, Nagpur, New Delhi, Noida, Pune, Udaipur
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Hyderabad, Kochi, Mumbai, Nagpur, Vijayawada
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 2/3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Belagavi, Coimbatore, Dehradun, Hyderabad, Jaipur, Kolkata, New Delhi, Thane
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwārka, Hyderabad, Jaipur, Kolkata, Mangalore, Mumbai, Nagpur, New Delhi, Pune, Telangana, Vijayawada
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - 4. fázisTaking peoplePost-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
- Where
- Bangalore, Dalgate, Drugjan, Hyderabad, Lucknow, Nagpur, New Delhi
- Életkor
- 18 év and over
- People
- 166
- Run by
- AstraZeneca
See details and how to joinNCT06531798 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Ahmedabad, Aligarh, Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Faridabad, Gūrgaon, Kochi, Kolkata, Kozhikode, Lucknow, Madurai, Mysuru, Nagpur, Pune, Telangana, Vadodara
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00